Voyager Therapeutics is trading at $1.76, down 5.11% in live trading on October 23, 2026, amid broader risk-off sentiment; no clear company-specific announcement explaining the decline has surfaced.
- Voyager’s CEO succession announcement was reported October 21, but available sources do not connect it to this move.
- The Dow was down 1.27%, and biotech’s XBI was down 2.08%; Reuters reported Brent crude above $114 amid Middle East tensions.
- Live volume information was not provided.